Go to lih.lu

AGENDA

Celebrating 10 Years of NCER-PD

📅 Dates: 16th and 17th October 2025
🇬🇧 Language: English
🏫 Venue: Maison du Savoir, Auditorium  A.3500, 2 avenue de l’Université, L-4365 Esch-sur-Alzette, Luxembourg

Day 1, 16 October 2025

TIMEPROGRAM 8h15-17h30
08:15 –  08:45Registration & Welcome coffee
08:45– 09:00Welcome address by organizers
09:00 – 09:45Keynote Speaker: Prof. Roger Barker, The current status and future of dopamine cell-based therapies for Parkinson’s, University of Cambridge, UK
Session 1: Clinical, Molecular and Pathological Stratification of PD
Chair: Prof. Dr. Nico Diederich, Centre Hospitalier de Luxembourg

09:45 – 10:15Prof. Kathrin Brockmann, Clinical and molecular stratification in preparation of clinical trials. University Tübingen, DE
10:15 –  10:45Prof. Dr. Per Borghammer, Brain first and body first PD – evidence and
implications, Aarhus University Hospital, DK
10:45 – 11:15Prof. Enza Maria Valente, Multimodal stratification of GBA-PD, University of Pavia, IT
11:15 – 11:30  Coffee break with exhibition and poster session
Session 2:  Patient-derived cellular modelling of neurodegeneration Chair: Prof. Dr. Anne Grünewald, University of Luxembourg
 11:30 –  12:00Prof. Céline Galvagnion, Disruptions in lipid levels associated with Parkinson’s Disease and alpha-synuclein pathology. University of Copenhagen, DK
 12:00 – 12:30Prof. Dr. Lena Burbulla, Investigating key players of neurodegenerative diseases using human disease modeling, Ludwig-Maximilians University Munich, DE
 12:30 –  13:00Prof. Dr. Edward Fon, Using functional genomics and iPSC models to understand the biology of Parkinson’s disease. McGill University, CA
 13:00 –  14:00    Walking lunch with exhibition and poster session
Session 3: Therapeutic innovations for Precision Medicine in PD Chair: Dr. Frank Hertel, Centre Hospitalier de Luxembourg
 14:00 – 14:30Prof. Dr. Thomas Gasser, Emerging therapies for genetically defined subgroups of PD, Hertie-Institute for Clinical Brain Research University of Tübingen,
 14:30 –  15:00Prof. Dr Andrea Kühn, New avenues for neuromodulation in PD for improved treatment and disease modification, Charité – Universitätsmedizin Berlin, DE
 15:00 –  15:30Prof. Dr. Werner Poewe, Targeting alpha-synuclein for disease modification in PD. Medical University in Innsbruck, AT
15:30 –  15:45     Coffee break with exhibition and poster session
Session 4: Dissecting the Genetic Architecture of PDChair: Dr. Patrick May, University of Luxembourg
15:45 – 16:15Prof. Andrew Singleton, The Global Parkinson’s Genetics Program: progress and future. Global Parkinson’s Genetics Program, US
 16:15 – 16:45Dr. Manu Sharma, From Mendelian genes to polygenic risk scores:
Widening the arc to understand disease risk and causality, University Tübingen, DE
 16:45 –  17:15Prof. Dr. Vincenzo Bonifati, Update on novel genes involved in PD pathogenesis, Erasmus University Rotterdam, NL
 17:15 – 17:30Closing remarks, Prof. Dr. Rejko Krüger, LIH, LCSB, CHL, LU

Day 2, 17 October 2025

TIMEPROGRAM 8h45-16h45
8:45 – 9:00Welcome coffee
Session 5: Cognition and Precision Prevention in PD Chair: Prof. Dr. Anja Leist, University of Luxembourg
9:00 – 9:30Prof. Dr. Elke Kalbe, Prevention of cognitive decline in people with
Parkinson´s disease: A call for action, University Hospital of Cologne, DE
9:30 – 10:00 Dr. Niels Janssen, Dementia risk reduction: from evidence to implementation. Maastricht University, NL
Session 6: Fire presentations
10:00 – 10:303 * 5+5 min (young researcher presentation based on abstract selection)
10:30 – 10:45      Coffee break with exhibition and poster session
Session 7: Biomarkers and biological classification of PD Chair: Prof. Dr. Enrico Glaab, University of Luxembourg
10:45 – 11:15Prof. Dr. Joaquim Ferreira, Defining the riddle in order to solve it: there is more than one Parkinson’s disease. University of Lisbon, Laboratory of Clinical Pharmacology and Therapeutics, PT
 11:15 – 11:45Prof. Dr. Christine Klein, New biological classification of Parkinson’s disease – implications for diagnostics; University of Lübeck, University Hospital Schleswig-Holstein; DE
 11:45 – 12:15Prof. Dr. Brit Mollenhauer, Update on emerging biomarkes in PD, Paracelsus-Elena Klinik, DE
 12:15 – 12:30FNR presentation TBC
12:30 – 13:30       Walking lunch with exhibition and poster session
Session 8: Epidemiology and Exposome in PD Chair: Dr. Brice Appenzeller, Luxembourg Institute of Health
 13:30 – 14:00Prof. Dr. Pille Taba, Does epidemiology lead to prognostic clues for PD? University of Tartu, ES
 14:00 – 14:30Prof. Mohammed Salama, Advances in technology used for environmental exposure assessment. American University in Cairo, EG
 14:30 – 15:00Prof. Dr. Alexis Elbaz, Improving causal inference in epidemiologic studies of Parkinson’s disease. Pitié-Salpêtrière Hospital, INSERM, FR
Session 9: Deep Phenotyping in Cohorts for Prodromal stages of PDChair: Prof. Dr. Jochen Klucken, University of Luxembourg
 15:00 – 15:30Dr. Kenneth Marek, Parkinson Progression Marker Initiative (PPMI) – Driving
biologic definition and Neuronal Synuclein Disease staging to accelerate
therapeutic development for PD and related synucleinopathies. Institute for Neurodegenerative Disorders, US
 15:30 – 16:00Prof. Asha Kishore, Clinical phenotypes and risk factors for Parkinson’s disease in India, Aster Medcity, Kochi, IN
 16:00 – 16:30Prof. Dr. Nobutaka Hattori, Innovations from molecular phenotyping of Parkinson’s disease for diagnosis and treatment, Juntendo University, RIKEN, JP
 16:30 – 16:45Closing remarks

2025 © Celebrating 10 Years of NCER-PD